-
1
-
-
80053426842
-
Targeted therapies for breast cancer
-
doi:10.1172/JCI57152. PubMed: 21965336
-
Higgins MJ, Baselga J (2011) Targeted therapies for breast cancer. J Clin Invest 121: 3797-3803. doi:10.1172/JCI57152. PubMed: 21965336.
-
(2011)
J Clin Invest
, vol.121
, pp. 3797-3803
-
-
Higgins, M.J.1
Baselga, J.2
-
2
-
-
77950633401
-
New strategies in estrogen receptor-positive breast cancer
-
doi: 10.1158/1078-0432.CCR-09-1823. PubMed: 20332324
-
Johnston SR (2010) New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res 16: 1979-1987. doi: 10.1158/1078-0432.CCR-09-1823. PubMed: 20332324.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1979-1987
-
-
Johnston, S.R.1
-
3
-
-
0037169354
-
Cancer susceptibility and the functions of BRCA1 and BRCA2
-
doi:10.1016/S0092-8674(02)00615-3. PubMed: 11832208
-
Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182. doi:10.1016/S0092-8674(02)00615-3. PubMed: 11832208.
-
(2002)
Cell
, vol.108
, pp. 171-182
-
-
Venkitaraman, A.R.1
-
4
-
-
32044453343
-
X chromosomal abnormalities in basal-like human breast cancer
-
doi:10.1016/j.ccr.2006.01.013. PubMed: 16473279
-
Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M et al. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121-132. doi:10.1016/j.ccr.2006.01.013. PubMed: 16473279.
-
(2006)
Cancer Cell
, vol.9
, pp. 121-132
-
-
Richardson, A.L.1
Wang, Z.C.2
De Nicolo, A.3
Lu, X.4
Brown, M.5
-
5
-
-
59449098395
-
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas
-
doi:10.1158/1078-0432.CCR-08-1291. PubMed: 19047089
-
Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N et al. (2008) Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin Cancer Res 14: 7645-7651. doi:10.1158/1078-0432.CCR-08- 1291. PubMed: 19047089.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7645-7651
-
-
Walsh, C.S.1
Ogawa, S.2
Scoles, D.R.3
Miller, C.W.4
Kawamata, N.5
-
6
-
-
84856158117
-
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
-
doi:10.1001/jama.2012.20. PubMed: 22274685
-
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ et al. (2012) Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA 307: 382-390. doi:10.1001/jama.2012.20. PubMed: 22274685.
-
(2012)
JAMA
, vol.307
, pp. 382-390
-
-
Bolton, K.L.1
Chenevix-Trench, G.2
Goh, C.3
Sadetzki, S.4
Ramus, S.J.5
-
7
-
-
17244373777
-
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
-
doi:10.1038/nature03445. PubMed: 15829967
-
Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921. doi:10.1038/nature03445. PubMed: 15829967.
-
(2005)
Nature
, vol.434
, pp. 917-921
-
-
Farmer, H.1
McCabe, N.2
Lord, C.J.3
Tutt, A.N.4
Johnson, D.A.5
-
8
-
-
84864026311
-
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian Ovarian Cancer Study Group
-
doi:10.1200/JCO.2011.39.8545. PubMed: 22711857
-
Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C et al. (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30: 2654-2663. doi:10.1200/JCO.2011.39.8545. PubMed: 22711857.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2654-2663
-
-
Alsop, K.1
Fereday, S.2
Meldrum, C.3
DeFazio, A.4
Emmanuel, C.5
-
9
-
-
79959838081
-
Integrated genomic analyses of ovarian carcinoma
-
doi:10.1038/nature10166. PubMed: 21720365
-
Bell D, Berchuck A, Birrer M, Chien J, Cramer DW et al. (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615. doi:10.1038/nature10166. PubMed: 21720365.
-
(2011)
Nature
, vol.474
, pp. 609-615
-
-
Bell, D.1
Berchuck, A.2
Birrer, M.3
Chien, J.4
Cramer, D.W.5
-
10
-
-
77958484951
-
The genesis and evolution of high-grade serous ovarian cancer
-
doi:10.1038/nrc2946. PubMed: 20944665
-
Bowtell DD (2010) The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10: 803-808. doi:10.1038/nrc2946. PubMed: 20944665.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 803-808
-
-
Bowtell, D.D.1
-
11
-
-
84867536072
-
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome
-
doi: 10.1158/1078-0432.CCR-12-0857. PubMed: 22912389
-
Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A et al. (2012) Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res 18: 5806-5815. doi: 10.1158/1078-0432.CCR-12- 0857. PubMed: 22912389.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 5806-5815
-
-
Wang, Z.C.1
Birkbak, N.J.2
Culhane, A.C.3
Drapkin, R.4
Fatima, A.5
-
12
-
-
84866261844
-
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-Mutation damaging agents
-
doi: 10.1158/2159-8290.CD-11-0206 PubMed: 22576213
-
Birkbak NJ, Wang ZC, Kim JY, Eklund AC, Li Q et al. (2012) Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-Mutation damaging agents. Cancer Discov 2: 366-375. doi: 10.1158/2159-8290.CD-11-0206 PubMed: 22576213.
-
(2012)
Cancer Discov
, vol.2
, pp. 366-375
-
-
Birkbak, N.J.1
Wang, Z.C.2
Kim, J.Y.3
Eklund, A.C.4
Li, Q.5
-
13
-
-
77950974130
-
Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors
-
doi:10.1158/1078-0432.CCR-09-2758. PubMed: 20371688
-
Mukhopadhyay A, Elattar A, Cerbinskaite A, Wilkinson SJ, Drew Y et al. (2010) Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. Clin Cancer Res 16: 2344-2351. doi:10.1158/1078-0432.CCR-09-2758. PubMed: 20371688.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2344-2351
-
-
Mukhopadhyay, A.1
Elattar, A.2
Cerbinskaite, A.3
Wilkinson, S.J.4
Drew, Y.5
-
14
-
-
84861550476
-
The life history of 21 breast cancers
-
doi: 10.1016/j.cell.2012.04.023. PubMed: 22608083
-
Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD et al. (2012) The life history of 21 breast cancers. Cell 149: 994-1007. doi: 10.1016/j.cell.2012.04.023. PubMed: 22608083.
-
(2012)
Cell
, vol.149
, pp. 994-1007
-
-
Nik-Zainal, S.1
Van Loo, P.2
Wedge, D.C.3
Alexandrov, L.B.4
Greenman, C.D.5
-
15
-
-
80053950209
-
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer
-
doi:10.1001/jama.2011.1456. PubMed: 21990299
-
Yang D, Khan S, Sun Y, Hess K, Shmulevich I et al. (2011) Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 306: 1557-1565. doi:10.1001/jama.2011.1456. PubMed: 21990299.
-
(2011)
JAMA
, vol.306
, pp. 1557-1565
-
-
Yang, D.1
Khan, S.2
Sun, Y.3
Hess, K.4
Shmulevich, I.5
-
16
-
-
84873441292
-
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation
-
doi:10.1073/pnas.1221068110. PubMed: 23345422
-
Tomasetti C, Vogelstein B, Parmigiani G (2013) Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A 110: 1999-2004. doi:10.1073/pnas. 1221068110. PubMed: 23345422.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 1999-2004
-
-
Tomasetti, C.1
Vogelstein, B.2
Parmigiani, G.3
-
17
-
-
84866256092
-
Mechanisms of BRCA1 tumor suppression
-
doi: 10.1158/2159-8290.CD-12-0221 PubMed: 22843421
-
Silver DP, Livingston DM (2012) Mechanisms of BRCA1 tumor suppression. Cancer Discov 2: 679-684. doi: 10.1158/2159-8290.CD-12-0221 PubMed: 22843421.
-
(2012)
Cancer Discov
, vol.2
, pp. 679-684
-
-
Silver, D.P.1
Livingston, D.M.2
-
18
-
-
82455218968
-
BRCA1 is required for postreplication repair after UV-induced DNA damage
-
doi:10.1016/j.molcel.2011.09.002. PubMed: 21963239
-
Pathania S, Nguyen J, Hill SJ, Scully R, Adelmant GO et al. (2011) BRCA1 is required for postreplication repair after UV-induced DNA damage. Mol Cell 44: 235-251. doi:10.1016/j.molcel.2011.09.002. PubMed: 21963239.
-
(2011)
Mol Cell
, vol.44
, pp. 235-251
-
-
Pathania, S.1
Nguyen, J.2
Hill, S.J.3
Scully, R.4
Adelmant, G.O.5
-
19
-
-
77951878399
-
Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass
-
doi:10.1038/onc.2010.18. PubMed: 20173781
-
Xie J, Litman R, Wang S, Peng M, Guillemette S et al. (2010) Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass. Oncogene 29: 2499-2508. doi:10.1038/onc.2010.18. PubMed: 20173781.
-
(2010)
Oncogene
, vol.29
, pp. 2499-2508
-
-
Xie, J.1
Litman, R.2
Wang, S.3
Peng, M.4
Guillemette, S.5
-
20
-
-
84882837534
-
Signatures of mutational processes in human cancer
-
doi:10.1038/nature12477. PubMed: 23945592
-
Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S et al. (2013) Signatures of mutational processes in human cancer. Nature 500: 415-421. doi:10.1038/nature12477. PubMed: 23945592.
-
(2013)
Nature
, vol.500
, pp. 415-421
-
-
Alexandrov, L.B.1
Nik-Zainal, S.2
Wedge, D.C.3
Aparicio, S.A.4
Behjati, S.5
-
21
-
-
79952746216
-
Secondary mutations of BRCA1/2 and drug resistance
-
doi:10.1111/j.1349-7006.2010.01840.x. PubMed: 21205087
-
Dhillon KK, Swisher EM, Taniguchi T (2011) Secondary mutations of BRCA1/2 and drug resistance. Cancer Sci 102: 663-669. doi:10.1111/j.1349-7006.2010. 01840.x. PubMed: 21205087.
-
(2011)
Cancer Sci
, vol.102
, pp. 663-669
-
-
Dhillon, K.K.1
Swisher, E.M.2
Taniguchi, T.3
-
22
-
-
4944229642
-
Hallmarks of 'BRCAness' in sporadic cancers
-
doi:10.1038/nrc1457. PubMed: 15510162
-
Turner N, Tutt A, Ashworth A (2004) Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 4: 814-819. doi:10.1038/nrc1457. PubMed: 15510162.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 814-819
-
-
Turner, N.1
Tutt, A.2
Ashworth, A.3
-
23
-
-
77950958141
-
53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks
-
doi:10.1016/j.cell.2010.03.012. PubMed: 20362325
-
Bunting SF, Callén E, Wong N, Chen HT, Polato F et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141: 243-254. doi:10.1016/j.cell.2010.03.012. PubMed: 20362325.
-
(2010)
Cell
, vol.141
, pp. 243-254
-
-
Bunting, S.F.1
Callén, E.2
Wong, N.3
Chen, H.T.4
Polato, F.5
-
24
-
-
84862776819
-
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
-
doi:10.1016/j.molcel.2012.02.015. PubMed: 22445484
-
Bunting SF, Callén E, Kozak ML, Kim JM, Wong N et al. (2012) BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell 46: 125-135. doi:10.1016/j.molcel.2012.02.015. PubMed: 22445484.
-
(2012)
Mol Cell
, vol.46
, pp. 125-135
-
-
Bunting, S.F.1
Callén, E.2
Kozak, M.L.3
Kim, J.M.4
Wong, N.5
-
25
-
-
39149118956
-
Optimal chemotherapy treatment for women with recurrent ovarian cancer
-
doi:10.3747/co.2007.148. PubMed: 17938703
-
Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, et al. (2007) Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14: 195-208. doi:10.3747/co.2007.148. PubMed: 17938703.
-
(2007)
Curr Oncol
, vol.14
, pp. 195-208
-
-
Fung-Kee-Fung, M.1
Oliver, T.2
Elit, L.3
Oza, A.4
Hirte, H.W.5
-
26
-
-
69949167276
-
A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6
-
doi:10.1093/bioinformatics/btp371. PubMed: 19535535
-
Bengtsson H, Wirapati P, Speed TP (2009) A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 25: 2149-2156. doi:10.1093/bioinformatics/btp371. PubMed: 19535535.
-
(2009)
Bioinformatics
, vol.25
, pp. 2149-2156
-
-
Bengtsson, H.1
Wirapati, P.2
Speed, T.P.3
-
27
-
-
77951996044
-
TumorBoost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays
-
doi: 10.1186/1471-2105-11-245. PubMed: 20462408
-
Bengtsson H, Neuvial P, Speed TP (2010) TumorBoost: normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics 11: 245. doi: 10.1186/1471-2105-11-245. PubMed: 20462408.
-
(2010)
BMC Bioinformatics
, vol.11
, pp. 245
-
-
Bengtsson, H.1
Neuvial, P.2
Speed, T.P.3
-
28
-
-
84864023860
-
CalMaTe: A method and software to improve allele-specific copy number of SNP arrays for downstream segmentation
-
doi:10.1093/bioinformatics/bts248. PubMed: 22576175
-
Ortiz-Estevez M, Aramburu A, Bengtsson H, Neuvial P, Rubio A (2012) CalMaTe: a method and software to improve allele-specific copy number of SNP arrays for downstream segmentation. Bioinformatics 28: 1793-1794. doi:10.1093/bioinformatics/bts248. PubMed: 22576175.
-
(2012)
Bioinformatics
, vol.28
, pp. 1793-1794
-
-
Ortiz-Estevez, M.1
Aramburu, A.2
Bengtsson, H.3
Neuvial, P.4
Rubio, A.5
-
29
-
-
78049248432
-
Allele-specific copy number analysis of tumors
-
doi:10.1073/pnas.1009843107. PubMed: 20837533
-
Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH et al. (2010) Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 107: 16910-16915. doi:10.1073/pnas.1009843107. PubMed: 20837533.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 16910-16915
-
-
Van Loo, P.1
Nordgard, S.H.2
Lingjaerde, O.C.3
Russnes, H.G.4
Rye, I.H.5
|